Emil D Kakkis's Net Worth
$285 Million
Estimate Recalculated Apr 19, 2024 03:38PM EST
Who is Emil D Kakkis?
Emil D Kakkis has an estimated net worth of $285 Million. This is based on reported shares across multiple companies, which include Ultragenyx Pharmaceutical Inc., and BIOMARIN PHARMACEUTICAL INC.
SEC CIK
Emil D Kakkis's CIK is 0001248093
Past Insider Trading and Trends
2008 was Emil D Kakkis's most active year for acquiring shares with 14 total transactions. Emil D Kakkis's most active month to acquire stocks was the month of February. 2008 was Emil D Kakkis's most active year for disposing of shares, totalling 169 transactions. Emil D Kakkis's most active month to dispose stocks was the month of March. 2007 saw Emil D Kakkis paying a total of $2,455,762.59 for 165,020 shares, this is the most they've acquired in one year. In 2021 Emil D Kakkis cashed out on 108,047 shares for a total of $14,090,922.66, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $44.875
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.47% | 24.14K |
$53.69 | -$935,118.73 | 563.91K |
Mar 1
| |||
Form 4
| -5.27% | -30.00K |
$45.00 | -$1,350,000.00 | 539.77K |
Feb 7
| |||
Form 4
| -5.00% | -30.00K |
$47.87 | -$1,436,100.00 | 569.77K |
Dec 29
| |||
Form 4
|
—
|
0
|
$20.19 | -$1,275,760.98 | 1.25M |
Oct 19
| |||
Form 4
| +3.30% | 38.78K |
$45.65 | -$736,791.00 | 1.21M |
Mar 1
| |||
Form 4
| -3.49% | -19.58K |
$45.57 | -$892,351.74 | 541.11K |
Scheduled
|
Dec 30
| ||
Form 4
| +6.71% | 39.88K |
$67.37 | -$819,353.94 | 634.23K |
Mar 1
| |||
Form 4
| -0.14% | -853.00 |
$81.00 | -$69,093.00 | 594.35K |
Oct 14
| |||
Form 4
| -0.14% | -852.00 |
$115.71 | -$98,584.92 | 595.2K |
May 6
| |||
Form 4
| -1.31% | -30.00K |
$107.80 | -$3,234,000.00 | 2.26M |
Scheduled
|
May 3
| ||
Form 4
| -0.44% | -12.89K |
$142.14 | -$6,582,244.74 | 2.89M |
Scheduled
|
Mar 1
| ||
Form 4
| -1.27% | -30.00K |
$136.90 | -$4,107,000.00 | 2.33M |
Scheduled
|
Jan 4
| ||
Form 4
| -1.26% | -30.00K |
$96.82 | -$2,904,600.00 | 2.36M |
Scheduled
|
Nov 2
| ||
Form 4
| -0.14% | -852.00 |
$92.69 | -$78,971.88 | 610.19K |
Oct 14
| |||
Form 4
| -1.24% | -30.00K |
$82.63 | -$2,478,900.00 | 2.39M |
Scheduled
|
Sep 1
| ||
Form 4
| -1.63% | -40.00K |
$85.35 | -$3,414,000.00 | 2.42M |
Scheduled
|
Jul 13
| ||
Form 4
| -0.22% | -1.33K |
$69.38 | -$92,552.92 | 611.04K |
Jun 1
| |||
Form 4
| -0.13% | -852.00 |
$66.26 | -$56,453.52 | 652.8K |
May 6
| |||
Form 4
| -0.13% | -851.00 |
$58.57 | -$49,843.07 | 653.65K |
Apr 19
| |||
Form 4
| +29.66% | 149.7K |
$3.01 | $449,998.20 | 654.5K |
Mar 12
| |||
Form 4
| +6.07% | 28.89K |
$56.08 | -$386,727.68 | 504.8K |
Mar 1
| |||
Form 4
| +0.73% | 3.44K |
—
|
—
| 475.91K |
Oct 14
| |||
Form 4
| +1.07% | 5K |
$43.63 | $218,150.00 | 472.48K |
Sep 11
| |||
Form 4
| -0.28% | -1.33K |
$54.93 | -$72,892.11 | 467.48K |
Jun 1
| |||
Form 4
| -0.30% | -1.41K |
$59.50 | -$84,133.00 | 468.81K |
May 21
| |||
Form 4
| +0.74% | 3.44K |
—
|
—
| 470.22K |
May 6
| |||
Form 4
| -0.17% | -798.00 |
$64.43 | -$51,415.14 | 466.79K |
Apr 19
| |||
Form 4/A
| +3.80% | 17.11K |
$65.52 | -$189,352.80 | 467.58K |
Mar 1 - Mar 5
| |||
Form 4
| +3.82% | 17.2K |
$67.55 | -$189,275.10 | 467.67K |
Mar 1
| |||
Form 4
| -0.21% | -926.00 |
$73.73 | -$68,273.98 | 450.47K |
Jun 1
| |||
Form 4
| -0.22% | -986.00 |
$64.79 | -$63,882.94 | 451.4K |
May 21
| |||
Form 4
| +0.76% | 3.43K |
—
|
—
| 452.38K |
Apr 19
| |||
Form 4
| +4.27% | 18.39K |
$48.43 | -$53,951.02 | 448.95K |
Mar 1
| |||
Form 4
| +0.29% | 7.5K |
$52.52 | $393,922.32 | 2.56M |
Aug 28
| |||
Form 4
| -0.23% | -1.01K |
$56.61 | -$56,949.66 | 430.57K |
Jun 1
| |||
Form 4
| -0.25% | -1.07K |
$57.47 | -$61,607.84 | 431.57K |
May 21
| |||
Form 4
| +3.10% | 13K |
—
|
—
| 432.65K |
Mar 1
| |||
Form 4
| -4.28% | -20.00K |
$81.29 | -$1,625,753.15 | 447.15K |
Scheduled
|
Nov 15
| ||
Form 4
| -4.11% | -20.00K |
$63.02 | -$1,260,360.40 | 467.15K |
Scheduled
|
Oct 14
| ||
Form 4
| -3.94% | -20.00K |
$67.61 | -$1,352,250.81 | 487.15K |
Scheduled
|
Aug 15
| ||
Form 4
| -3.79% | -20.00K |
$50.85 | -$1,016,908.50 | 507.15K |
Scheduled
|
Jul 15
| ||
Form 4
| +2.07% | 10.7K |
—
|
—
| 527.15K |
Jun 1
| |||
Form 4
| -0.21% | -1.07K |
$64.01 | -$68,618.72 | 516.45K |
May 21
| |||
Form 4
| -3.72% | -20.00K |
$59.95 | -$1,199,094.65 | 517.52K |
Scheduled
|
May 16
| ||
Form 4
| -3.59% | -20.00K |
$70.33 | -$1,406,553.86 | 537.52K |
Scheduled
|
Apr 15
| ||
Form 4
| -3.36% | -20.00K |
$114.52 | -$2,290,491.27 | 575.64K |
Scheduled
|
Dec 30 - Dec 31
| ||
Form 4
| -3.25% | -20.00K |
$98.27 | -$1,965,426.86 | 595.64K |
Scheduled
|
Nov 30
| ||
Form 4
| -3.15% | -20.00K |
$99.57 | -$1,991,407.00 | 615.64K |
Scheduled
|
Oct 30
| ||
Form 4
| +1.83% | 11.4K |
—
|
—
| 635.64K |
May 21
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
∞
| 624.24K |
—
|
—
| 624.24K |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $89.7
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$9.07 | -$41,617.98 | 39.62K |
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
$12.79 | -$216,063.20 | 39.62K |
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
$11.94 | -$191,354.90 | 39.62K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$11.00 | -$165,580.00 | 39.62K |
Scheduled
|
Dec 1
| ||
Form 4
| -65.43% | -75.00K |
$15.98 | -$1,198,740.00 | 39.62K |
Nov 25
| |||
Form 4
| -0.59% | -683.00 |
$12.19 | -$205,624.78 | 114.62K |
Scheduled
|
Oct 31 - Nov 3
| ||
Form 4
|
—
|
0
|
$16.20 | -$362,538.00 | 115.3K |
Scheduled
|
Oct 1
| ||
Form 4
| -9.43% | -12.00K |
$18.16 | -$506,604.00 | 115.3K |
Scheduled
|
Sep 2
| ||
Form 4
| -12.39% | -18.00K |
$32.48 | -$584,578.41 | 127.3K |
Scheduled
|
Aug 1
| ||
Form 4
| -11.02% | -18.00K |
$28.06 | -$505,076.00 | 145.3K |
Scheduled
|
Jul 7
| ||
Form 4
| +1.55% | 2.5K |
—
|
—
| 163.3K |
Jul 7
| |||
Form 4
| -1.23% | -2.00K |
$20.82 | -$613,367.12 | 160.8K |
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +1.02% | 1.64K |
$21.01 | -$585,850.37 | 162.8K |
Scheduled
|
Apr 30 - May 1
| ||
Form 4
| +87.04% | 75K |
$4.00 | $300,000.00 | 161.16K |
Apr 29
| |||
Form 4
| -10.27% | -9.86K |
$35.90 | -$353,835.48 | 86.16K |
Scheduled
|
Apr 1
| ||
Form 4
| +11.44% | 9.86K |
$19.88 | -$219,120.25 | 96.02K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$21.08 | -$614,870.00 | 86.16K |
Scheduled
|
Mar 6
| ||
Form 4
| -8.46% | -7.96K |
$6.92 | $14,100.92 | 86.16K |
Oct 31 - Dec 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +3.27% | 2.98K |
$5.19 | $15,461.67 | 94.13K |
Apr 30
| |||
Form 4
| +131.08% | 50K |
$4.00 | $200,000.00 | 88.14K |
Jan 4 - Jan 4
| |||
Form 4
| +12.93% | 4.37K |
$3.43 | $14,999.71 | 38.14K |
Oct 31 - Nov 20
| |||
Form 4
| +14.21% | 4.2K |
$3.43 | $14,429.67 | 33.78K |
Apr 28
| |||
Form 4
| +9.53% | 2.57K |
$3.43 | $8,832.25 | 29.57K |
Oct 31 - Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
| +7.86% | 1.97K |
$3.43 | $6,758.11 | 27K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +8.33% | 1.92K |
$3.51 | $6,754.20 | 25.03K |
Oct 31
| |||
Form 4
| +135.01% | 15K |
$6.49 | $97,400.00 | 26.11K |
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
$7.29 | -$5,810.66 | 11.11K |
Scheduled
|
Dec 29
| ||
| No matching records found | |||||||||